Andrea Paola Fuentes, MD
Neurology · San Diego
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 16
- 2 carriers
- Offices
- 2
Offices
2 locations · Regents of the University of California · 2,047 clinicians in this group
Hospitals listed: Stanford Health Care · UC San Diego Health Hillcrest - Hillcrest Med Ctr. That is not proof they admit you there this week.
Plans that list them
16 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Fuentes’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
16 of 16 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A171442 · Current
Licensed to practise in California · since 2021 · expires 2027-02-28 · University of California, San Diego School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
- UC San Diego Health Hillcrest - Hillcrest Med CtrSan Diego, CAAcute Care Hospital · Voluntary non-profit - Other · Has an emergency department · Birthing-friendlyPart of University of California Health, which runs 12 hospitalsHome of Moores Comprehensive Cancer Center, a National Cancer Institute designated comprehensive cancer centrePatients rate it 3 of 5 · 75% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Death rate among surgical inpatients with serious treatable complications: 105.39 (74.34 to 136.44) · 381 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.597, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.618, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.375, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.376, Oct 2024 – Sep 2025
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
See every measure and the patient survey for UC San Diego Health Hillcrest - Hillcrest Med Ctr
Behind the star rating — Deaths: 6 better, 2 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 8 the same, 2 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 105.39 (74.34 to 136.44) · 381 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.597 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.618 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.375 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.376 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.83 (0.11 to 1.54) · 3,862 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.84 to 1.2) | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.4 · 130 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.2 · 116 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.1 · 183 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 7.8 · 510 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 11 · 696 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.4 · 435 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 5,739 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.15 (0 to 0.32) · 12,387 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.44) · 13,596 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.59 (3.24 to 5.94) · 4,389 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.04 (0 to 2.12) · 2,419 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.26 (1.23 to 3.29) · 4,116 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.93 (6.61 to 13.25) · 2,232 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.31 (5.24 to 9.38) · 2,410 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.32 (1.07 to 3.56) · 1,286 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.38 (0.02 to 0.75) · 11,838 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.5 · 181 cases | None | Apr 2023 – Mar 2025 |
| MRSA BacteremiaInfections | 0.716 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.672 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.5 · 302 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.3 · 891 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 3.8 · 216 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 5.9 · 620 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 12 · 731 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 15.7 · 946 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.9 (4.8 to 7) · 1,507 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.3 (10.7 to 14) · 1,507 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 7.1 · 191 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.7 · 177 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.7 · 204 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 10.4 (8.5 to 13) · 4,116 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1) · 2,130 cases | No different | Jan 2024 – Dec 2024 |
What patients said (3,680 patients answered, 16% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 66% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 75% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 73% |
| Staff "always" explained new medications | 73% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 75% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 49% |
| "YES", patients would definitely recommend the hospital | 75% |
| Staff "always" explained possible side effects | 48% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
Original Medicare doctor bills
$47,891
Medicare paid this office $47,891 for 193 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Long return visit (40+ min) | 79 | $12,623 | $129 |
| Return visit (30+ min) | 61 | $6,062 | $87 |
| New patient visit (60+ min) | 33 | $5,106 | $155 |
| Return visit (30+ min) | 29 | $4,938 | $120 |
| Long return visit (40+ min) | 18 | $3,285 | $164 |
See all 13 services
| Long return visit (40+ min) | 79 | $12,623 | $129 |
| Return visit (30+ min) | 61 | $6,062 | $87 |
| New patient visit (60+ min) | 33 | $5,106 | $155 |
| Return visit (30+ min) | 29 | $4,938 | $120 |
| Long return visit (40+ min) | 18 | $3,285 | $164 |
| New patient visit (45+ min) | 16 | $1,916 | $120 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 74 | $1,405 | $15 |
| Short return visit (20+ min) | 21 | $1,308 | $59 |
| Short return visit (20+ min) | 14 | $1,237 | $88 |
| Electronic analysis of implanted brain, spinal cord, or peripheral neurostimulator generator with brain stimulator programming, first 15 minutes with qualified health professional | 13 | $1,038 | $42 |
| Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 19 | $846 | $28 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 30 | $643 | $15 |
| Muscle electrical test | 15 | $518 | $18 |
Procedures Medicare counted
| Skin biopsy | 1-10 | None |
Who their Medicare patients are
193 Original Medicare patients in 2024. Average age 75 · Under 65 7% · 85 and older 10% · Women 53% · Also on Medicaid 20% · Health risk score 1.44. At or below the middle of the specialty; the typical neurology clinician is at 1.61.
Conditions among them: High blood pressure 62% · Depression 35% · Dementia 23% · Diabetes 22% · Coronary heart disease 22% · Chronic kidney disease 19% · Atrial fibrillation 19% · Cancer 17% · Stroke 13% · Heart failure 11% · COPD 9%.
The office billed $180,278, Medicare allowed $61,271 and paid $47,891; for 612 services of 22 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 193 | 612 | 75 | 1.44 | $180,278 | $47,891 |
| 2023 | 144 | 278 | 73 | 1.32 | $117,256 | $22,887 |
| 2022 | 158 | 277 | 72 | 1.30 | $171,281 | $22,258 |
| 2021 | 86 | 196 | 71 | 1.16 | $100,901 | $16,227 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 6 services
| Long return visit (40+ min) | 53 | $7,753 | $127 |
| Long return visit (40+ min) | 32 | $3,774 | $111 |
| New patient visit (60+ min) | 21 | $3,265 | $155 |
| New patient visit (60+ min) | 15 | $1,736 | $116 |
| Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 29 | $1,030 | $26 |
| Muscle electrical test | 16 | $268 | $17 |
2022: 4 services
| Long return visit (40+ min) | 84 | $9,765 | $110 |
| New patient visit (60+ min) | 52 | $6,789 | $131 |
| Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 34 | $1,544 | $27 |
| Muscle electrical test | 16 | $294 | $16 |
2021: 3 services
| Long return visit (40+ min) | 53 | $7,155 | $133 |
| New patient visit (60+ min) | 32 | $5,225 | $163 |
| Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 41 | $2,145 | $29 |
Drugs they prescribed that Part D paid
$271,561
Pharmacies billed $271,561 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
539 generic and fewer than 11 brand-name prescriptions · $271,561 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Austedo | None | 12 | $64,690 | $5,391 |
| Rytary | Parkinson's | 24 | $48,747 | $2,031 |
| Carbidopa | None | 14 | $13,450 | $961 |
| Carbidopa-Levodopa | None | 139 | $6,961 | $50 |
| Carbidopa-Levodopa Er | None | 76 | $3,515 | $46 |
See all 15 drugs
| Austedo | None | 12 | $64,690 | $5,391 |
| Rytary | Parkinson's | 24 | $48,747 | $2,031 |
| Carbidopa | None | 14 | $13,450 | $961 |
| Carbidopa-Levodopa | None | 139 | $6,961 | $50 |
| Carbidopa-Levodopa Er | None | 76 | $3,515 | $46 |
| Amantadine | None | 44 | $2,914 | $66 |
| Mirtazapine | None | 31 | $928 | $30 |
| Clonazepam | None | 26 | $773 | $30 |
| Gabapentin | None | 11 | $640 | $58 |
| Primidone | None | 12 | $490 | $41 |
| Propranolol | None | 23 | $466 | $20 |
| Rivastigmine | None | 11 | $347 | $32 |
| Pramipexole Dihydrochloride | None | 15 | $327 | $22 |
| Fludrocortisone Acetate | None | 13 | $287 | $22 |
| Donepezil | None | 25 | $226 | $9 |
Year by year
| 2024 | 606 | 126 | None | None | $271,561 |
| 2023 | 272 | 89 | 0% (0) | 14% | $82,390 |
| 2022 | 312 | 101 | None | 17% | $96,053 |
| 2021 | 242 | 64 | 0% (0) | 11% | $112,017 |
| 2020 | 239 | 38 | 0% (0) | 5% | $16,080 |
| 2019 | 212 | 44 | 0% (0) | None | $11,760 |
| 2018 | 120 | 26 | 0% (0) | None | $19,250 |
| 2017 | 42 | 18 | 0% (0) | None | $3,731 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 7 drugs
| Rytary | Parkinson's | 22 | $17,707 | $805 |
| Carbidopa-Levodopa | None | 52 | $3,683 | $71 |
| Carbidopa-Levodopa Er | None | 30 | $1,876 | $63 |
| Donepezil | None | 14 | $293 | $21 |
| Primidone | None | 11 | $190 | $17 |
| Quetiapine | None | 13 | $137 | $11 |
| Fludrocortisone Acetate | None | 12 | $60 | $5 |
2022: 6 drugs
| Rytary | Parkinson's | 17 | $18,013 | $1,060 |
| Myrbetriq | None | 21 | $10,924 | $520 |
| Carbidopa-Levodopa | None | 81 | $5,612 | $69 |
| Carbidopa-Levodopa Er | None | 14 | $1,033 | $74 |
| Donepezil | None | 20 | $382 | $19 |
| Fludrocortisone Acetate | None | 14 | $255 | $18 |
2021: 6 drugs
| Xadago | 11 | $10,868 | $988 |
| Carbidopa-Levodopa | 19 | $996 | $52 |
| Levetiracetam | 37 | $615 | $17 |
| Cyclobenzaprine | 12 | $192 | $16 |
| Gabapentin | 11 | $142 | $13 |
| Donepezil | 14 | $124 | $9 |
2020: 8 drugs
| Levetiracetam | 44 | $776 | $18 |
| Gabapentin | 23 | $566 | $25 |
| Baclofen | 13 | $444 | $34 |
| Ondansetron | 13 | $280 | $22 |
| Atorvastatin | 13 | $153 | $12 |
| Sertraline | 13 | $121 | $9 |
| Donepezil | 14 | $115 | $8 |
| Cyclobenzaprine | 12 | $13 | $1 |
2019: 6 drugs
| Levetiracetam | 30 | $752 | $25 |
| Gabapentin | 16 | $470 | $29 |
| Baclofen | 13 | $288 | $22 |
| Atorvastatin | 13 | $256 | $20 |
| Sertraline | 19 | $131 | $7 |
| Duloxetine | 11 | $129 | $12 |
2018: 1 drug
| Levetiracetam | 11 | $303 | $28 |
Money from drug and device companies
$357 in 2025
| 2025 | 3 | 11 | None | $357 |
| 2024 | 1 | 3 | None | $155 |
| 2023 | 2 | 10 | None | $444 |
| 2022 | 4 | 28 | None | $11,632 |
| 2021 | 3 | 4 | None | $16,300 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Medtronic | Percept PC Brainsense | $279 | 9 payments
|
| Boston Scientific | General - Dbs | $59 | 1 payment
|
| Abbvie | Vyalev | $18 | 1 payment
|
See all 11 published payments
| Medtronic | Meals · 2025-11-17 | Percept PC Brainsense | $21 |
| Medtronic | Meals · 2025-10-01 | Percept PC Brainsense | $81 |
| Boston Scientific | Meals · 2025-06-10 | General - Dbs | $59 |
| Medtronic | Meals · 2025-04-24 | Percept PC Brainsense | $120 |
| Medtronic | Meals · 2025-03-25 | Percept PC Brainsense | $22 |
| Medtronic | Meals · 2025-03-19 | Percept PC Brainsense | $24 |
| Medtronic | Meals · 2025-03-18 | Percept PC Brainsense | $2 |
| Medtronic | Meals · 2025-03-18 | Percept PC Brainsense | $1 |
| Medtronic | Meals · 2025-03-15 | Percept PC Brainsense | $3 |
| Medtronic | Meals · 2025-03-15 | Percept PC Brainsense | $5 |
| Abbvie | Meals · 2025-01-07 | Vyalev | $18 |
See earlier years (2024, 2023, 2022, 2021)
2024: $155
| Boston Scientific | None | $155 | 3 payments
|
2023: $444
| Medtronic | Percept PC Brainsense | $314 | 4 payments
|
| Abbvie | Botox | $130 | 6 payments
|
2022: $11,632
| Boston Scientific | Vercise | $6,427 | 4 payments
|
| Medtronic | Activa PC | $5,091 | 19 payments
|
| Abbvie | Botox | $86 | 4 payments
|
| Abbott Laboratories | Infinity | $28 | 1 payment
|
2021: $16,300
| Boston Scientific | Vercise | $10,030 | 2 payments
|
| Medtronic | Activa | $6,250 | 1 payment
|
| Biohaven Pharmaceuticals | Nurtec Odt | $20 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 76.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1003342585
- Licence
- CA A171442California A171442: Current · expires 2027-02-28
- Trained
- University of California, San Diego School of Medicine, 2017
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Medicaid ID
- CA 95525321G06281
- Taxonomy
- Neurology (2084N0400X)
- Mailing address
- File 57326, Los Angeles, CA, 90074
- NPI first listed
- 2017-05-03
- NPI last updated
- 2025-06-02
- NPI record certified
- 2025-06-02
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 10679 Canyon Lake Dr, San Diego, CA, 92131 · 4510 Executive Dr, San Diego, CA, 92121 · 1635 Divisadero St Ste 520, San Francisco, CA, 94115 · 300 Pasteur Dr, Stanford, CA, 94305